HRSA loan repayment program aims to boost opioid treatment access

Jan 07, 2019 - 02:49 PM
hrsa-service-corps

The Health Resources and Services Administration recently launched a program to provide eligible health care clinicians with student loan repayment assistance in exchange for their service on the front lines of the opioid crisis in underserved communities. The National Health Service Corps Substance Use Disorder Workforce Loan Repayment Program will boost access to preventive, treatment and recovery services for those struggling with substance use disorder, according to HRSA. Clinicians accepted to the program may receive up to $75,000 for three years of full-time service at a health care facility that has been designated by HRSA as an NHSC-approved substance use disorder site. A part-time service option also is available. Applications are due Feb. 21. 
 

Related News Articles

Headline
HHS awards additional $487 million to states for opioid response
The Department of Health and Human Services this week awarded $487 million in fiscal year 2019 grants to help states and territories increase access to…
Headline
Groups sue HHS for approving NH Medicaid work requirements
The National Health Law Program and other groups yesterday filed a class action lawsuit against the Department of Health and Human Services for approving a…
Headline
Report: OUD treatments effective, but barriers prevent wider use
The three medications approved by the Food and Drug Administration to treat opioid use disorder — methadone, buprenorphine and extended-release naltrexone —…
Headline
Study: Medicaid work requirements could weaken hospitals’ finances
Hospitals in states that impose Medicaid work requirements could see reduced Medicaid revenues and operating margins and increased uncompensated care costs,…
Headline
CDC: One-third of uninsured skimped on prescription medicines because of cost
About 34 percent of uninsured U.S. adults did not take their medication as prescribed in 2017 in order to reduce their prescription drug costs, according to a…
Headline
Study finds marked decline in first-time opioid prescriptions
In a study of Blue Cross and Blue Shield enrollees reported last week in the New England Journal of Medicine, initial opioid prescriptions declined 54 percent…